If you made any changes in Pure these will be visible here soon.

Impacts

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)

Impact: Quality of life Impacts, Economic Impacts